Here's the Next Stock I'm Going to Buy
Stock market volatility can create great opportunities for long-term investors. The recent growth stock sell-off has produced a handful of attractive valuations, and I'm excited to scoop up some great investments at a discount. The next time I move cash into the market, I'm going to buy more of a tech stock that is set to capitalize on the inevitable growth of the life sciences industry.
Veeva Systems (NYSE: VEEV) provides cloud-based software with a variety of applications in the life sciences market. Its customers include pharmaceutical companies, biotechs, research organizations, device makers, and other manufacturers. Veeva offers a range of products and services that generally fall into two categories: R&D and commercial.
The research and development segment enables data management and patient engagement through clinical trials. There are also important tools for regulatory compliance, document filing, payments, quality assurance, and clinical data analysis. On the commercial side, Veeva offers customer relationship management (CRM) tools to support sales teams, along with analytics and marketing tools.
Source Fool.com
